KJHP
TBIO

K.J. Harrison & Partners’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

K.J. Harrison & Partners’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-867
Closed -$26K – 251
2022
Q3 		$26K Sell
867
-1,355
-61% -$47.7K 0.01% 167
2022
Q2 		$72K Hold
2,222
– – 0.02% 180
2022
Q1 		$215K Buy
+2,222
New +$337K 0.03% 225

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

K.J. Harrison & Partners's TBIO Position: Q4 2022 in Review

K.J. Harrison & Partners sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q4 2022, closing a stake of 867 shares — an estimated $26K sold.

K.J. Harrison & Partners first reported a position in TBIO in Q1 2022 and held it in 3 quarters. The position peaked at $215K in Q1 2022. 24 funds tracked by Wall St. Rank hold TBIO as of Q4 2022.

  • K.J. Harrison & Partners reported no remaining Telesis Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • K.J. Harrison & Partners sold 867 Telesis Bio, Inc. Common Stock shares in Q4 2022, an estimated $26K.
  • K.J. Harrison & Partners first reported a position in Telesis Bio, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • K.J. Harrison & Partners's Telesis Bio, Inc. Common Stock position peaked at $215K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q4 2022.

Based on K.J. Harrison & Partners's 13F filing for Q4 2022, filed 25 Jan 2023.